Total Payments
$4,695
2024 Payments
$527.42
Companies
34
Transactions
263
Medicare Patients
1,718
Medicare Billing
$177,442
Payment Breakdown by Category
Food & Beverage$4,606 (98.1%)
Gifts$59.40 (1.3%)
Education$29.99 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,606 | 261 | 98.1% |
| Gift | $59.40 | 1 | 1.3% |
| Education | $29.99 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $596.62 | 38 | $0 (2024) |
| Antares Pharma, Inc. | $442.98 | 18 | $0 (2024) |
| Amgen Inc. | $361.39 | 22 | $0 (2024) |
| Allergan, Inc. | $332.60 | 15 | $0 (2021) |
| PFIZER INC. | $330.66 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $300.18 | 5 | $0 (2021) |
| Lilly USA, LLC | $285.96 | 14 | $0 (2023) |
| Depomed, Inc. | $217.36 | 1 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $211.39 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $210.42 | 20 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $527.42 | 36 | Amgen Inc. ($144.20) |
| 2023 | $1,327 | 77 | ABBVIE INC. ($286.28) |
| 2022 | $542.96 | 36 | Antares Pharma, Inc. ($210.36) |
| 2021 | $839.82 | 59 | AbbVie Inc. ($254.19) |
| 2020 | $842.70 | 49 | Allergan, Inc. ($179.90) |
| 2019 | $147.00 | 2 | Allergan Inc. ($122.71) |
| 2018 | $115.19 | 1 | Janssen Pharmaceuticals, Inc ($115.19) |
| 2017 | $353.16 | 3 | Depomed, Inc. ($217.36) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.95 | General |
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.56 | General |
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $6.15 | General |
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.50 | General |
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Obesity | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.41 | General |
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.69 | General |
| 07/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Inflammation | ||||||
| 07/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: PAIN | ||||||
| 06/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 371 | 505 | $76,749 | $42,101 |
| 2022 | 12 | 505 | 748 | $88,564 | $47,892 |
| 2021 | 8 | 409 | 529 | $78,841 | $44,862 |
| 2020 | 7 | 433 | 658 | $92,592 | $42,587 |
Total Patients
1,718
Total Services
2,440
Medicare Billing
$177,442
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $24,800 | $15,145 | 61.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 186 | $29,760 | $14,271 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 135 | $13,500 | $7,435 | 55.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 25 | $5,250 | $2,751 | 52.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,395 | $1,726 | 72.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $540.00 | $401.88 | 74.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $504.00 | $370.92 | 73.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 202 | $32,320 | $15,831 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 122 | 122 | $24,415 | $15,380 | 63.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 157 | $15,700 | $8,379 | 53.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 19 | $3,990 | $2,363 | 59.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $2,795 | $2,085 | 74.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 21 | 29 | $2,871 | $1,188 | 41.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 35 | 35 | $1,575 | $1,107 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,470 | $1,060 | 72.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 39 | $1,638 | $317.91 | 19.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $650.00 | $121.33 | 18.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 12 | $420.00 | $41.26 | 9.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 72 | $720.00 | $17.30 | 2.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 209 | $33,440 | $16,776 | 50.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 124 | 124 | $24,800 | $15,928 | 64.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 125 | $12,500 | $6,915 | 55.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 11 | 12 | $3,600 | $2,498 | 69.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 12 | 12 | $2,580 | $1,955 | 75.8% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 15 | 15 | $675.00 | $425.55 | 63.0% |
About Paul John
Paul John is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679681357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul John has received a total of $4,695 in payments from pharmaceutical and medical device companies, with $527.42 received in 2024. These payments were reported across 263 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,606).
As a Medicare-enrolled provider, John has provided services to 1,718 Medicare beneficiaries, totaling 2,440 services with total Medicare billing of $177,442. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 08/25/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679681357
Products in Payments
- NURTEC ODT (Drug) $550.61
- VRAYLAR (Drug) $533.98
- UBRELVY (Drug) $312.35
- XARELTO (Drug) $300.18
- Otezla (Drug) $239.57
- MOUNJARO (Drug) $217.89
- Nucynta (Drug) $217.36
- XIFAXAN (Drug) $211.39
- TRINTELLIX (Drug) $151.46
- NOCDURNA (Drug) $134.89
- TLANDO (Drug) $124.57
- Repatha (Biological) $121.82
- TRELEGY ELLIPTA (Drug) $114.78
- Cologuard Collection Kit (Device) $98.41
- OTREXUP (Drug) $97.58
- CHANTIX (Drug) $96.42
- FARXIGA (Drug) $89.10
- XYOSTED (Drug) $85.94
- JATENZO (Drug) $85.73
- QULIPTA (Drug) $74.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Family Medicine $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
Family Medicine $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Family Medicine $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Family Medicine $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Family Medicine $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768
Family Medicine $32,768